10x Genomics Inc - Ordinary Shares - Class A
TXG
Market Cap$1.74B
Close$
$42.06
215.3% upside
Current Fair Value
215.3% upsideUndervalued by 215.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.74 Billion |
|---|---|
| Enterprise Value | $1.53 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.52 |
| Beta | 2.03 |
| Outstanding Shares | 123,755,409 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -20.49 |
|---|---|
| PEG | 10.72 |
| Price to Sales | 2.67 |
| Price to Book Ratio | 2.22 |
| Enterprise Value to Revenue | 2.38 |
| Enterprise Value to EBIT | -14.88 |
| Enterprise Value to Net Income | -19 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.24 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About 10x Genomics Inc
CEO: Serge Saxonov